Paul Hébert

Dr. Paul C. Hébert is President of the Canadian Institutes of Health Research (CIHR), Canada's federal health-research funding agency, beginning his term in 2025. A clinician-scientist and professor of medicine at the University of Ottawa, he is internationally known for landmark transfusion and critical-care trials, including the pivotal TRICC study, and formerly served as Editor-in-Chief of the Canadian Medical Association Journal.